Bringing a drug from the clinical trial stages to market is a long and expensive process, which is why sponsors often streamline the process by outsourcing their clinical trial management to contract research organizations (CROs). ClinDART, a small CRO based in San Diego, provides its pharmaceutical, biotech, and medical device company clients with the necessary flexibility, extensive knowledge, and expertise in clinical trial data management necessary to optimize efficiency. It is essential for ClinDART to use an electronic data capture (EDC) software platform that can help it accomplish this. This is why ClinDART is excited to offer Medrio as an EDC option; Medrio’s easy-to-use software provides ClinDART with the ability to build its studies in days instead of weeks or months.
The Medrio Difference
While ClinDART has tried many EDC providers, it has found Medrio to be the easiest to use with the most user-friendly interface, helping it to create and deploy its studies quickly and efficiently. Recently, ClinDART put Medrio to the test and built a simple sleep study in both Medrio CloudEDC™ and Oracle RDC to analyze the use of the two systems. A 20 page study that took 6 hours to build in Medrio took 48 hours to build in Oracle RDC. “Not all studies require the complexity and build effort of RDC. In these cases, other options are desirable. Medrio can be perfect in these situations because it saves so much time,” said Diana Brady, President of ClinDART.
ClinDART also found that making the transition to Medrio from another EDC provider was easy. Jen Cottrell, a ClinDART Data Manager, appreciates this, saying: “With Medrio, the learning curve is straight up. With just a two day training we came back and could build a study with ease. There’s no need for technically specialized experts. This, combined with fast build times and the low cost of the database build, makes Medrio a perfect fit for Phase I studies.” While other EDC software is cumbersome and requires years of ongoing training, neither a technical background nor extensive training is needed to build a study in Medrio.
“With Medrio, the learning curve is straight up. With just a two day training we came back and could build a study with ease. There’s no need for technically specialized experts. This, combined with fast build times and the low cost of the database build, makes Medrio a perfect fit for Phase I studies.”
— Jen Cottrell, Clinical Data Manager at ClinDART
Using Medrio, ClinDART is able to quickly and effortlessly build a study without any programming knowledge. To prepare people to use the software, Medrio offers a two-day intensive training session, which fully trains users on configuration, data entry, monitoring and analysis. Medrio is dedicated to bringing its customers software that is user-friendly, intuitive, and 75% less expensive than the competition.
Founded in 2008, ClinDART is a pioneer in designing custom data management and statistical programming solutions that maximize the chances of a successful clinical trial in pharmaceutical, biotech, and medical device industries. Leveraging decades of combined experience, a thorough knowledge of the clinical trial process, and broad access to system resources, ClinDART ensures that your data is managed in the most logical, efficient, and compliant manner, in turn saving you substantial time and money.
For more information please visit: http://www.clindart.com/.
Medrio offers an integrated eClinical software platform with a fully hosted EDC system. Their revolutionary CloudEDC™ technology features an easy to use drag-and-drop interface, allowing study managers to build their studies in days instead of months without any programming required. Medrio’s new mobile suite, mSource, supports both event-based and subject-based workflows, offline data entry, and PRO. Although Medrio has vast experience in all study phases, with over 500 Phase I trials to date, our m1 application leads the way in early phase and Phase I trials. Plus, Medrio costs up to 75% less than traditional EDC solutions!
For more information please visit: www.medrio.com.